NCT05101772

Brief Summary

The screened patients were randomly assigned 25G puncture needles and 22G puncture needles in a 1;1 ratio, based on the computer-generated random order, before receiving an ultrasound endoscope puncture. Each puncture needle puncture lesions 2 needles, the same type of puncture needle tissue samples taken in the same tissue pathology bottle, all tissues after the completion of the necessary cytological smears, are placed in the Formalin solution to send tissue pathology, pathologists do not know the order of distribution of 2 puncture needles to evaluate the tissue results, all pathology results are reported by the hospital pathology center, audit.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
73

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2021

Completed
6 days until next milestone

Study Start

First participant enrolled

September 24, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 24, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 24, 2022

Completed
Last Updated

November 8, 2021

Status Verified

September 1, 2021

Enrollment Period

7 months

First QC Date

September 18, 2021

Last Update Submit

November 1, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • The acquisition rate of the core tissue sample

    A core tissue sample is defined as a sample with an histological structure that is fully used for tissue evaluation of target lesions.

    One week

Secondary Outcomes (3)

  • The length of the tissue strip

    One week

  • the technical success rate 、the success rate of immunogrouping dyeing and the retention of the organizational structure

    One week

  • the incidence of adverse events and the incidence of device defects

    one week

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The subjects were 18 years of age or older (inclusive) who were clinically diagnosed with solid pancreatic masses or submucosal masses and required endoscopic ultrasound-guided puncture examination. Seventy-three subjects are planned to be enrolled.

You may qualify if:

  • Clinical diagnosis of real pancreatic swelling or submuscular swelling;
  • Patients need to be guided by ultrasound endoscopy under the guidance of puncture to eliminate malignant lesions or clear lesions;
  • Fully communicate before surgery, understand the risks and benefits of endoscopic operation, and sign an informed consent form.

You may not qualify if:

  • There are endoscopic operation contraindications, including abnormal blood clotting, or long-term oral anticoagulant antiplatelet drugs, can not guarantee INR \< 1.5, or platelets less than 5 x 10 x 9 / L;
  • Pregnant woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Third Xiangya Hospital of Central South University

Changsha, Hunan, 410013, China

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Pancreatic or submucosal tissue

MeSH Terms

Conditions

Pancreatic Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Central Study Contacts

Yunlu Feng, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2021

First Posted

November 1, 2021

Study Start

September 24, 2021

Primary Completion

April 24, 2022

Study Completion

May 24, 2022

Last Updated

November 8, 2021

Record last verified: 2021-09

Locations